Literature DB >> 1614244

S-100 protein in human inner ear: use of a novel immunohistochemical technique on routinely processed, celloidin-embedded human temporal bone sections.

S R Shi1, A K Tandon, C Coté, K L Kalra.   

Abstract

The authors recently developed a new antigen retrieval technique which allows immunohistochemical detection of proteins in routinely processed, celloidin-embedded human temporal bone sections. This technique was used in the present study, which reports the occurrence of S-100 protein in the human inner ear. Fifteen celloidin-embedded human temporal bone sections, obtained from the Eastern Temporal Bone Bank at the Massachusetts Eye and Ear Infirmary, were tested with the monoclonal antibody to S-100. This protein was found in the spiral ligament, in Reissner's membrane, in the spiral limbus, and in the basement membrane of the cochlea. S-100-positive, thin fibers could be seen as supporting elements in the acoustic nerve and the facial nerve. This protein was localized along the surface of vestibular wall. The new technique provides an immunohistochemical approach to studying routinely processed human temporal bone sections and may prove useful in the field of immuno-otopathology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614244     DOI: 10.1288/00005537-199207000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

Review 1.  Immunohistochemical techniques for the human inner ear.

Authors:  Ivan A Lopez; Gail Ishiyama; Seiji Hosokawa; Kumiko Hosokawa; Dora Acuna; Fred H Linthicum; Akira Ishiyama
Journal:  Histochem Cell Biol       Date:  2016-08-01       Impact factor: 4.304

2.  Expression of S-100 protein in the human fetal inner ear.

Authors:  H Yamashita; M Takahashi; D Bagger-Sjöbäck
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

3.  Zika virus infection causes widespread damage to the inner ear.

Authors:  Kathleen T Yee; Biswas Neupane; Fengwei Bai; Douglas E Vetter
Journal:  Hear Res       Date:  2020-06-29       Impact factor: 3.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.